MRCGP, FRACGP, PhD, MBBS
Prof Paul Glasziou
Director (CREBP)
Faculty of Health Sciences and Medicine
Bond University QLD 4229
Australia
Professional Biography
Paul Glasziou FRACGP, PhD is Professor of Evidence-Based Medicine at Bond University and a part-time General Practitioner. He was the Director of the Centre for Evidence-Based Medicine in Oxford from 2003-2010. His key interests include identifying and removing the barriers to using high quality research in everyday clinical practice. He is the author of six books related to evidence based practice: Systematic Reviews in Health Care, Decision Making in Health Care and Medicine: integrating evidence and values, An Evidence-Based Medicine Workbook, Clinical Thinking: Evidence, Communication and Decision-making, Evidence-Based Medicine: How to Practice and Teach EBM, and Evidence-Based Medical Monitoring: Principles and Practice. He has authored over 160 peer-reviewed journal articles and his h-index is currently 43. He is the recipient of an NHMRC Australia Fellowship which he commenced at Bond University in July, 2010.
Qualifications
Member of the Royal College of General Practioners
Fellowship of the Royal Australian College of General Practitioners
Doctor of Philosophy
Bachelor of Medicine Bachelor of Surgery – University of Queensland
Recent Keynote Addresses
Navigating the Future
GP10 Conference, RACGP
Research interests & research expertise
Improving medical decision making, including clinical trials, systematic reviews and evidence-based medicine, with specific applications to breast and colorectal cancer screening, otitis media, cholesterol lowering, and anticoagulation for atrial fibrillation.
Current research grants
NHMRC Program Grant on screening & diagnosis
Recent Publications
- Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies
- Self diagnosis
- A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trials
- Tonsillectomy or adeno-tonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis (Review)
- Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- Event rates, hospital utilization, and costs associated with major complications of diabetes: A multicountry comparative analysis
- Review: Stopping randomized trials early for benefit and estimation of treatment effects: Systematic review and meta-regression analysis
- What are the basic self-monitoring components for cardiovascular risk management?
- Can evidence-based medicine and clinical quality improvement learn from each other?
- Letter to the editor: Antibiotics and acute otitis media in children
- Problems and promises of innovation: Why healthcare needs to rethink its love/hate relationship with the new
- Patterns of ‘leakage’ in the utilisation of clinical guidelines: A systematic review
- The rise of cholesterol testing: How much is unnecessary
- Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infections before starting antiretroviral therapy
- Grading quality of evidence and strength of recommendations in clinical practice guidelines Part 3 of 3. The GRADE approach to developing recommendations
- Buteyko breathing for asthma (protocol)
- Point-of-care testing for Hb A1c in the management of diabetes: A systematic review and metaanalysis
- Letter to the editor: Treatment of acute otitis media in children
- Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: Is it cost-effective?
- Self-monitoring of oral anticoagulation: A systematic review and meta-analysis